Michael A. Darwin, Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 23,318 shares at $19.08 ($449K) on 2006-03-15, disclosed to the SEC on 2006-03-17.
Scheduled sale ($449k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.00 | 1,983 | $38K | 8.4% |
| 2 | $19.01 | 600 | $11K | 2.5% |
| 3 | $19.02 | 700 | $13K | 3.0% |
| 4 | $19.03 | 100 | $2K | 0.4% |
| 5 | $19.04 | 100 | $2K | 0.4% |
| 6 | $19.05 | 471 |
| $9K |
| 2.0% |
| 7 | $19.06 | 913 | $17K | 3.9% |
| 8 | $19.08 | 200 | $4K | 0.8% |
| 9 | $19.10 | 1,737 | $33K | 7.4% |
| 10 | $19.15 | 4,500 | $86K | 19.2% |
| 11 | $19.16 | 200 | $4K | 0.9% |
| 12 | $19.25 | 300 | $6K | 1.3% |
| 13 | $19.30 | 4,946 | $95K | 21.3% |
| 14 | $19.31 | 400 | $8K | 1.7% |
| 15 | $19.32 | 400 | $8K | 1.7% |
| 16 | $19.33 | 300 | $6K | 1.3% |
| 17 | $19.34 | 800 | $15K | 3.4% |
| 18 | $19.35 | 1,700 | $33K | 7.3% |
| 19 | $19.37 | 300 | $6K | 1.3% |
| 20 | $19.45 | 100 | $2K | 0.4% |
| 21 | $19.46 | 200 | $4K | 0.9% |
| 22 | $19.47 | 1,700 | $33K | 7.4% |
| 23 | $21.00 | 668 | $14K | 3.1% |
| Total | $19.26 avg | 23,318 | $449K | 100% |
| Filing → |